Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Arq. bras. endocrinol. metab ; 42(5): 363-7, out. 1998. tab
Article in English | LILACS | ID: lil-262199

ABSTRACT

Bone mineral density (BMD) is reduced in the distal radius, proximal femur and lumbar spine of hypogonadal individuals. The objective of the present cross-sectional study was to assess cranial BMD by dual energy X-ray absorptiometry in patients with hypogonadism arising during the first two decades of life, submitted or not to hormone replacement, as well as in menopausal women not submitted to hormone replacement. Cranial BMD was significantly lower in hypogonadal without treatment (1.656 + 0.24 g/cm2; mean + SD) when compared to normal young individuals (1.996 + 0.17). The cranial bone mass did not differ significantly between untreated and treated young hypogonadal individuals (1.779 + 0.32 g/cm2). The values detected in both groups were significantly lower than those detected in the menopausal women (2.146 + 0.29 g/cm2; p<0.01). The cranial BMD of patients with primary hypogonadism did not differ from that of patients with central hypogonadism and confirmed growth hormone deficiency (1.654 + 0.23 versus 1.601 + 0.16 g/cm2). We conclude that hypogonadism of early onset is associated with a marked reduction in cranial BMD, a finding probably due to the high sensitivity of trobecular bone to sex steroid deficiency and to the interference of this deficiency with the achievement of bone mass peak.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Skull/physiology , Bone Density/physiology , Hypogonadism/physiopathology , Menopause/physiology , Absorptiometry, Photon , Skull
2.
Arq. bras. endocrinol. metab ; 40(3): 198-202, set. 1996. ilus, tab
Article in Portuguese | LILACS | ID: lil-209598

ABSTRACT

Com a finalidade de estabelecer valores referenciais para as concentraçöes basais de gonadotrofinas séricas avaliadas através do método de quimioluminescência, foram dosados o LH e o FSH em 148 crianças e adolescentes nos vários estágios puberais. Para os meninos, o valores de LH e FSH, em UI/L, expressos como média e intervalo de confiança, foram no estágio I 1,00 (0,47-1,53) e 1,78 (1,26-2,30); no estágio II, 1,16 (0,39-1,94) e 3,31 (2,08-4,53); no estágio III 2,28 (1,45-3,12) e 3,71 (2,56-4,85) e, nos estágios IV e V 4,10 (3,25-4,94) e 8,94 (4,48-13,40). Nas meninas, os valores foram no estágio 10,48 (0,34-0,62) e 3,50 (2,58-4,42); noestágio II, 1,92 (-0,12-3,96) e 5,93 (2,34-9,53); no estágio III 4,41 (1,85-6,96) e 8,40 (6,07-10,73) e, nos estágios IV e V 6,39 (4,00-8,78) e 7,57 (5,35-9,80). A porcentagem de valores indetectáveis foi de 9,45 para o LH e 3,37 para o FSH, todos os casos ocorrendo nos estágios I e II da puberdade. Foram observadas diferenças significativas entre os valores pré-puberais e os encontrados a partir do estágio III de puberdade. Constatou-se, no entanto, a ocorrência de sobreposiçäo de valores nos diferentes estágios do desenvolvimento puberal.


Subject(s)
Humans , Male , Female , Child, Preschool , Child , Adolescent , Follicle Stimulating Hormone/blood , Luteinizing Hormone/blood , Gonadal Disorders/blood , Gonadal Disorders/diagnosis , Luminescent Measurements , Puberty , Reference Values
SELECTION OF CITATIONS
SEARCH DETAIL